Alexion beefs up Soliris IP to help keep biosimilars at bay
Alexion has strengthened its Soliris (eculizumab) manufacturing IP and is developing a longer-acting C5 antibody ahead of potential biosimilar competition.
Archives for July 28, 2016
Thermo Fisher: ‘Biopharma’s drive for efficiency plays into our sweet spot’
Increased biologics both on the market and in development and demand for greater manufacturing efficiencies have led to another strong quarter for Thermo Fisher.
Single-use, manifold benefits: Parker adds UK production capacity for bioprocessing tech
Parker domnick hunter has added manufacturing capacity at its facility in Birtley, UK to better supply European biopharmaceutical industry customers.